https://scholars.lib.ntu.edu.tw/handle/123456789/523422| Title: | Nanomodified strategies to overcome EGFR-tyrosine kinase inhibitors resistance in non-small cell lung cancer | Authors: | Tseng, S.-Ja Yang, Pan-Chyr Kempson I.M. Li H.-J. S.-JA TSENG PAN-CHYR YANG |
Issue Date: | 2020 | Publisher: | Elsevier B.V. | Journal Volume: | 324 | Start page/Pages: | 482-492 | Source: | Journal of Controlled Release | URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85085949121&doi=10.1016%2fj.jconrel.2020.05.043&partnerID=40&md5=e1a6599cd4ef5f4588fe0de0b36ba6c1 https://scholars.lib.ntu.edu.tw/handle/123456789/523422 |
ISSN: | 0168-3659 | DOI: | 10.1016/j.jconrel.2020.05.043 | SDG/Keyword: | [SDGs]SDG3 Amino acids; Biological organs; Cell signaling; Drug products; Enzyme inhibition; Acquired resistance; Clinical efficacy; Efficient treatment; Epidermal growth factor receptors; Non small cell lung cancer; Sustained release; Therapeutic outcomes; Tyrosine kinase inhibitor; Diseases; antineoplastic agent; epidermal growth factor receptor; lactic acid; nanocarrier; nucleic acid; plasmid DNA; protein tyrosine kinase inhibitor; virus vector; EGFR protein, human; epidermal growth factor receptor; protein kinase inhibitor; cancer immunotherapy; cancer resistance; cytoreductive surgery; DNA transfection; drug formulation; gene mutation; human; in vitro study; in vivo study; metastasis; nanopharmaceutics; nanotechnology; non small cell lung cancer; nonhuman; oncolytic virotherapy; priority journal; Review; RNAi therapeutics; sustained drug release; treatment outcome; tumor microenvironment; drug resistance; genetics; lung tumor; mutation; non small cell lung cancer; Carcinoma, Non-Small-Cell Lung; Drug Resistance, Neoplasm; ErbB Receptors; Humans; Lung Neoplasms; Mutation; Protein Kinase Inhibitors |
| Appears in Collections: | 醫學系 |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.